MONA AMIRKHANI: Open Payments
NPI 1831785237 · LAGUNA NIGUEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 42 payments from 15 companies in 2025. Trend: 2023 $645 · 2024 $638 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $196 |
| ABBVIE INC. | 9 | $195 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $161 |
| Novo Nordisk Inc | 4 | $99 |
| Kowa Pharmaceuticals America, Inc. | 4 | $82 |
| Lilly USA, LLC | 4 | $73 |
| Exact Sciences Corporation | 3 | $68 |
| Amgen Inc. | 2 | $51 |
| Indivior Inc. | 2 | $50 |
| Boston Scientific Corporation | 1 | $39 |
Products named: AIRSUPRA, VRAYLAR, Kerendia, ZORYVE, Ozempic, MOUNJARO, SUBLOCADE, Cologuard Collection Kit.
Industry payments across CA — which companies pay providers there.
